Your Article Summary
A long-term follow-up of botulinum toxin A in cervical dystonia
Neurological Research, 07/02/09
Mohammadi B et al. - These data confirm the efficacy and safety of BoNT-A treatment in CD over an extended period of up to 14 years.
Related Articles
Paramedical treatment in primary dystonia: A systematic review
Movement Disorders, 10/30/09
Relevance Score: 66%
Neck movement speed in cervical dystonia
Movement Disorders, 10/30/09
Relevance Score: 65%
Cervical dystonia
Future Neurology, 10/12/09
Relevance Score: 64%
A Severe Case of Complex Regional Pain Syndrome I (Reflex Sympathetic Dystrophy) Managed with Spinal Cord Stimulation
Pain Practice, 10/27/09
Relevance Score: 63%
Cervical Radicular Pain
Pain Practice, 10/07/09
Relevance Score: 47%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunosuppression Using the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus: Pilot Study Shows Significant Cognitive and Affective Improvement
Transplantation Proceedings, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
The effect of statin therapy on allergic patients with asthma
Annals of Allergy, Asthma, and Immunology, 12/16/09

See Latest Articles